Please, Signup (Login) to subscribe or trade (demo)
Opko Health Inc stock price
Opko Health Inc latest news:
BRIEF-Opko Health licensee Tesaro announces FDA approval of Varubi IV for delayed nausea, vomiting associated with ...
Opko Health Inc(OPK): * Opko Health(OPK) licensee Tesaro (TSRO) announces FDA approval of Varubi IV for delayed nausea and vomiting associated with chemotherapy. * Tesaro (TSRO) is expected to launch Varubi IV in November 2017 Source text for Eikon: Further company coverage: